SEC charges Theranos and CEO Elizabeth Holmes with fraud
The SEC alleges Theranos deceived investors by exaggerating or speaking falsely about what its technology could do.
by Rebecca Robbins
Mar 14, 2018
2 minutes
The Securities and Exchange Commission on Wednesday charged Theranos and CEO Elizabeth Holmes with fraud, capping off a remarkable downfall for a once high-flying company that promised to revolutionize the blood testing industry but instead became a parable for Silicon Valley hype and hubris.
The alleges that the privately held company deceived investors by exaggerating or falsifying everything from who it was working with to how
You’re reading a preview, subscribe to read more.
Start your free 30 days